grant
Building and Implementing Best Practices for Buprenorphine Initiation in the Setting of Fentanyl Use
Organization UNIVERSITY OF WASHINGTONLocation SEATTLE, UNITED STATESPosted 15 Aug 2023Deadline 31 Jul 2028
NIHUS FederalResearch GrantFY2025Absence of pain sensationAbsence of sensibility to painActiqAdanonAlthoseAssess implementationAwardAwarenessBuprenorphineCaringCertificationCessation of lifeClinicalCommunitiesComplexConsensusCounselingCountryDataData CollectionDeathDolophineDoseDrugsDuragesicEffectivenessEnrollmentFDA approvedFailureFeedbackFeels no painFentanestFentanylFentylFundingFutureGoalsHospitalsImplementation assessmentIndividualInpatientsInterviewInvestigatorsLifeLiteratureMedical centerMedicationMethadoneMethadoseMethodsMorbidityMorbidity - disease rateNalorexNaltrexoneNatureNemexinNo sensitivity to painOpiate agonistOpiate receptor agonistOpiatesOpioidOpioid agonistOpioid receptor agonistOut-patientsOutcomeOutpatientsPatient CarePatient Care DeliveryPatientsPenetrationPersonsPharmaceutical PreparationsPhasePhentanylPhysiciansPilot ProjectsPractice GuidelinesPreparationPrevalenceProceduresProcessProviderQualitative MethodsQualitative ResearchRandomizedReViaReactionResearchResearch MethodologyResearch MethodsResearch PersonnelResearch SupportResearch TrainingResearchersRespiratory DepressionReview LiteratureRiskRuralSafetySecondary toSubstance Use DisorderTimeTrainingTreatment FailureVentilatory DepressionVivitrolWaiting ListsWithdrawalWorkaddictionaddictive disorderanalgesiabarriers to implementationcare for patientscare of patientscareercaring for patientsclinician factorsclinician-level factorsdepressed breathingdepression of breathingdrug/agenteffectiveness/implementation hybrid studyeffectiveness/implementation studyenrollevaluate implementationevaluation of implementationevidence baseexperiencefacilitators to implementationfeasibility testingfentanyl useimplementation barriersimplementation challengesimplementation evaluationimplementation facilitatorsimplementation scienceimprovedimproved outcomeinnovateinnovationinnovativelipophilicitymedication for opioid use disordermortalitymultidisciplinarynovelopiate consumptionopiate drug useopiate intakeopiate useopiate use disorderopioid consumptionopioid drug useopioid intakeopioid useopioid use disorderoverdose deathoverdose fatalitiesphysician factorsphysician-level factorspilot studypreferencepreparationsprovider factorsprovider-level factorsqualitative reasoningrandomisationrandomizationrandomly assignedrecruitrelative effectivenessresearch and methodsresponsesafety netsubstance use and disordertherapy failuretoolvirtualwaitlist
Description preview
PROJECT SUMMARY
Morbidity and mortality related to opioid use continue to rise, with fentanyl now the most
common opioid involved in overdose death. Despite three FDA approved medications for opioid
use disorder (MOUD)—methadone, buprenorphine, and naltrexone--as many as 3 out of 4
people with OUD are not on any of these lifesaving medications,…
🔒
Start 7-day free trial — $29.99/mo →Full details available on the Agency plan
Unlock the complete grant description, eligibility criteria, contract value, evaluation details and apply link — plus alerts, pipeline tracking, and CSV export.
Agency Plan
7-day free trialUnlock procurement & grants
Upgrade to access active tenders from World Bank, UNDP, ADB and more — with email alerts and pipeline tracking.
$29.99 / month
- 🔔Email alerts for new matching tenders
- 🗂️Track tenders in your pipeline
- 💰Filter by contract value
- 📥Export results to CSV
- 📌Save searches with one click